Design and evaluation of a novel floating osmotic pump system

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 12, Issue 1, 2009, Pages 129-137

  Zhang, Zhihong ^a   Peng, Bo ^a   Yang, Xinggang ^a   Wang, Chao ^a   Sun, Guangmei ^a   Pan, Weisan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; ADENOSINE;

AREA UNDER THE CURVE; ARTICLE; CONCENTRATION PROCESS; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; MATRIX TABLET; NONHUMAN; OSMOTIC PUMP; PH; TEMPERATURE; ABSORPTION; ANIMAL; CHEMISTRY; DRUG EFFECT; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION; OSMOSIS; OSMOTIC PRESSURE; PERMEABILITY; PHARMACEUTICS; PHYSIOLOGY; SOLUBILITY; TABLET;

ABSORPTION; ADENOSINE; ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DOGS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; OSMOSIS; OSMOTIC PRESSURE; PERMEABILITY; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 70349329276     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j33k5n     Document Type: Article

References (33)

1. Theeuwes, F. Elementary osmotic pump. J Pharm Sci, 1975; 64:1987-1991.
2. Lu EX, Jiang ZQ, Zhang QZ, Jiang XG. Preparation of controlled release coated tablets of naproxen sodium. Chin Pharm J, 2002; 37:841-844.
3. Defang O, Shufang N, Wei L, Hong G, Hui L, Weisan Pan. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev Ind Pharm, 2005; 31:677-685.
4. Okimoto K, Rajewski RA, Stella VJ. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-β-CD as both a solubilizing and an osmotic pump agent. J Control Release, 1999; 58:29-38.
5. Okimoto K, Tokunaga Y, Ibuki R, Irie T, Uekama K, Rajewski RA, Stella VJ. Applicability of (SBE) 7m-β-CD in controlled-porosity osmotic pump tablets (OPTs). Int J Pharm, 2004; 286:81-88.
6. Swanson DR, Barclay BL, Wong PSL, Theeuwes F. Nifedipine gastrointestinal therapeutic system. Am J Med, 1987; 83:3-9.
7. Kuczynski AL, Ayer AD, Patrick SLW. Oral hypoglycemic glipizide granulation. US Patent: 5024843, Jun 18, 1991.
8. Gan Y, Pan W, Wei M, Zhang R. Cyclodextrin Complex Osmotic Tablet for Glipizide Delivery. Drug Dev & Ind Pharm, 2002; 28:1015-1021.
9. Wu X, NIE S, Zhang N, Zheng Q, Hou P, Pan W. Preparation and in vitro release of nisoldipine two-layer osmotic pump tablets. Chin Pharm J, 2004; 39:46-48.
10. Liu L, Khang G, Rhee JM, Lee HB. Monolithic osmotic tablet system for nifedipine delivery. J Control Release, 2000; 67:309-322.
11. Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release, 2002; 79:7-27.
12. Verma RK, Mishra B, Garg S. Osmotically controlled oral drug delivery. Drug Dev Ind Pharm 2000, 26:695-708.
13. Santus G., Baker RW. Osmotic drug delivery: a review of the patent literature. J Control Release, 1995; 33:1-21.
14. Davis DW. Method of swallowing a pill. US Patent 3 418 999, December 31, 1968.
15. Stops F, Fell JT, Collett JH, Martini LG, Sharma HL, Smith AM. Citric acid prolongs the gastro-retention of a floating dosage form and increases bioavailability of riboflavin in the fasted state. Int J Pharm, 2006; 308:4-24.
16. Stops F, Fell JT, Collett JH, Martini LG. Floating dosage forms to prolong gastro-retention-The characterisation of calcium alginate beads. Int J Pharm, 2008; 350:301-311.
17. Hamdani J, Goole J, Moës AJ, Amighi K. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. Int J Pharm, 2006; 323:86-92.
18. Ritschel WA. Targeting in the gastrointestinal tract: new approaches, Methods Find. Exp Clin Pharmacol, 1991; 13:313-336.
19. Ali J, Arora S, Ahuja A, Babbar AK, Sharma RK, Khar RK, Baboota S. Formulation and development of hydrodynamically balanced system for metformin: In vitro and in vivo evaluation. Eur J Pharm & Biopharm, 2007; 67:196-201.
20. Xu X, Sun M, Zhi F, Hu Y. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: In vitro and in vivo evaluation in healthy volunteers. Int J Pharm, 2006; 310:139-145.
21. Harrigan RM. Drug delivery device for preventing contact of undissolved drug with the stomach lining. US Patent 4 055 178, October 25, 1977.
22. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release, 2000; 63:235-259.
23. Chakrabarti S, Freedman JE. Dipyridamole, cerebrovascular disease, and the vasculature. Vascul Pharmacol. 2008; 48:143-9.
24. Kong SY, Lin R, Chen GM. Preparation of Dipyridamole Floating Tablets in Stomach. Chin J Pharm, 2003; 34:395-397.
25. Chavanpatil M, Jain P, Chaudhari S, Shear R, Vavia P. Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation. Int J Phartm, 2005; 304:178-184.
26. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int J Pharm, 2004; 275:97-107.
27. Joseph NJ, Lakshmi S, Jayakrishnan A. A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. J Control Release, 2002; 79:71-79.
28. Schug BS, Brendel E, Wolf D, Wonnemann M, Blume HH. Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union. Eur J Pharm Sci, 2002; 15:279-285.
29. Shah VP, Tsong Y, Sathe P, Liu J. In Vitro Dissolution Profile Comparison-Statistics and Analysis of the Similarity Factor, f2. Pharm Res, 1998; 15:889-896.
30. Wang W, Cui G, Zhao Y, Liao J, Wang R, Zhou X. Studies on pharmacokinetics and relative bioavailability of dipyridamole sustained release pellets. Chin J New Drug, 2002; 11:612-615.
31. Qi Y, Gao Y, Zhang Y, Hao L, Fei H, Qu X, Zhu Y. The pharmacokinetics of dipyridamole administered in tragestrically in rats. Chin Pharm Bulletin, 2006; 22:379-380.
32. Lu EX, Jiang ZQ, Zhang QZ, Jiang XG. A water-insoluble drug monolithic osmotic tablet system utilizing gum Arabic as an osmotic, suspending expanding agent. J Control Release, 2003; 92:375-382.
33. Riegllman S, Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption. J Pharm. & Biopharm, 1980; 8:509-534.